retatrutide approval timeline FDA Status 2026: Everything We Know So Far New Weight Loss Drug Retatrutide:
Description
We will use this information as part of your personalized program plan
Safely and effectively used for over 65 years
doi: 10.1017/S0007114511006817
The company received positive end-of-Phase 2 feedback from the FDA and has indicated that Phase 3 initiation is on track for the third quarter of 2026
